Literature DB >> 27541444

Comprehensive study of angiogenic factors in women with endometriosis compared to women without endometriosis.

Gülen Yerlikaya1, Sukirthini Balendran2, Katharina Pröstling3, Theresa Reischer4, Peter Birner5, Rene Wenzl6, Lorenz Kuessel7, Berthold Streubel8, Heinrich Husslein9.   

Abstract

OBJECTIVE: Endometriosis is a benign gynaecological disease, affecting women during their reproductive years. Angiogenesis represents a crucial step in the pathogenesis of endometriosis, because endometriotic lesions require neovascularization. In this study several angiogenesis-related genes have been studied in the context of endometriosis. Some of the analyzed angiogenic factors as well as their interactions were studied the first time regarding a possible association with endometriosis. STUDY
DESIGN: This case-control study consisted of 205 biopsies of 114 patients comprising 61 endometriosis patients and 53 control patients. Among them in 29 cases paired samples were obtained. VEGFA, VEGFR2, HIF1A, HGF, NRP1, PDGFB, FGF18, TNFα, TGFB2, EPHB4, EPO and ANG mRNA expression was analyzed by qRT-PCR in ectopic tissue samples, in eutopic endometrium of women with and without endometriosis, and in unaffected peritoneum of women with and without endometriosis.
RESULTS: VEGFR2, HIF1A, HGF, PDGFB, NRP1 and EPHB4 are overexpressed in ectopic lesions compared to eutopic tissues. VEGFR2, HGF, PDGFB, NRP1, and EPHB4 showed highest mRNA levels in peritoneal implants, in contrast HIF1A showed the highest expression in ovarian endometriomas. Correlation analyses of angiogenic factors in ectopic lesions revealed the strongest associations between VEGFR2, PDGFB, and EPHB4. We further showed a significant upregulation of VEGFR2, HIF1A and EPHB4 in eutopic endometrium of women with endometriosis compared to that of controls and a trend towards upregulation of HGF. Additionally, a significant downregulation for HIF1A, HGF and EPHB4 was observed in unaffected peritoneal tissues of women with endometriosis compared to controls.
CONCLUSION: We identified new genes (EPHB4 and NRP1) that may contribute to angiogenesis in endometriosis beside known factors (VEGFA, VEGFR2, HIF1A, HGF, and PDGFB). Correlation studies revealed the putative importance of EBHB4 in association with endometriosis. Our analyses support preliminary reports that angiogenic factors seem to be differently expressed in peritoneal implants, ovarian endometriomas and deep infiltrating endometriosis. Our observation that angiogenic factors are differently expressed in the unaffected peritoneum of women with endometriosis compared to women without endometriosis underlines the importance of the peritoneum in the establishment of endometriosis.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Angiogenic factors; Endometriosis; Gene expression; Peritoneum

Mesh:

Substances:

Year:  2016        PMID: 27541444     DOI: 10.1016/j.ejogrb.2016.07.500

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  9 in total

Review 1.  The Clinical Applications of Endometrial Mesenchymal Stem Cells.

Authors:  Wanyun Zuo; Bingyu Xie; Chenglong Li; Yuhan Yan; Yangyi Zhang; Wei Liu; Jufang Huang; Dan Chen
Journal:  Biopreserv Biobank       Date:  2017-12-21       Impact factor: 2.300

2.  Curcumin treats endometriosis in mice by the HIF signaling pathway.

Authors:  Jie Ding; Shanshan Mei; Wen Cheng; Zhexin Ni; Chaoqin Yu
Journal:  Am J Transl Res       Date:  2022-04-15       Impact factor: 3.940

3.  Targeted Nanoparticles with High Heating Efficiency for the Treatment of Endometriosis with Systemically Delivered Magnetic Hyperthermia.

Authors:  Youngrong Park; Ananiya A Demessie; Addie Luo; Olena R Taratula; Abraham S Moses; Peter Do; Leonardo Campos; Younes Jahangiri; Cory R Wyatt; Hassan A Albarqi; Khashayar Farsad; Ov D Slayden; Oleh Taratula
Journal:  Small       Date:  2022-04-17       Impact factor: 15.153

4.  Inhibition of erythropoietin-producing hepatoma receptor B4 (EphB4) signalling suppresses the vascularisation and growth of endometriotic lesions.

Authors:  Jeannette Rudzitis-Auth; Sophia A Fuß; Vivien Becker; Michael D Menger; Matthias W Laschke
Journal:  Br J Pharmacol       Date:  2020-04-12       Impact factor: 8.739

5.  Does the Use of the "Proseek® Multiplex Oncology I Panel" on Peritoneal Fluid Allow a Better Insight in the Pathophysiology of Endometriosis, and in Particular Deep-Infiltrating Endometriosis?

Authors:  Alexandra Perricos; René Wenzl; Heinrich Husslein; Thomas Eiwegger; Manuela Gstoettner; Andreas Weinhaeusel; Gabriel Beikircher; Lorenz Kuessel
Journal:  J Clin Med       Date:  2020-06-26       Impact factor: 4.241

6.  FGA Controls VEGFA Secretion to Promote Angiogenesis by Activating the VEGFR2-FAK Signalling Pathway.

Authors:  Hui Li; E Cai; Hongyan Cheng; Xue Ye; Ruiqiong Ma; Honglan Zhu; Xiaohong Chang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-13       Impact factor: 6.055

Review 7.  Chronic Niche Inflammation in Endometriosis-Associated Infertility: Current Understanding and Future Therapeutic Strategies.

Authors:  Yi-Heng Lin; Ya-Hsin Chen; Heng-Yu Chang; Heng-Kien Au; Chii-Ruey Tzeng; Yen-Hua Huang
Journal:  Int J Mol Sci       Date:  2018-08-13       Impact factor: 5.923

8.  Evaluation of apoptosis and angiogenesis in ectopic and eutopic stromal cells of patients with endometriosis compared to non-endometriotic controls.

Authors:  Ali-Akbar Delbandi; Mahmoud Mahmoudi; Adel Shervin; Sahel Heidari; Roya Kolahdouz-Mohammadi; Amir-Hassan Zarnani
Journal:  BMC Womens Health       Date:  2020-01-06       Impact factor: 2.809

9.  A Comparative Study of Gene Expression in Menstrual Blood-Derived Stromal Cells between Endometriosis and Healthy Women.

Authors:  Seyedeh Saeideh Sahraei; Faezeh Davoodi Asl; Naser Kalhor; Mohsen Sheykhhasan; Hoda Fazaeli; Sanaz Soleymani Moud; Azar Sheikholeslami
Journal:  Biomed Res Int       Date:  2022-01-11       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.